Michael O'LearyAntibody-based immunotherapy shows promise in high-risk prostate cancerCANCER DIGEST – May 14, 2023 – In the first clinical trial of an antibody-based immunotherapy drug to show promise in men with advanced,...
Michael O'LearyNew combination therapy shows promise in advanced prostate cancerCANCER DIGEST – April 1, 2023 – Preliminary results of a clinical trial shows that a combination of two oral drugs provides a significant...
Michael O'LearyMen who consume colorful diet have less prostate cancer riskCANCER DIGEST – March 10, 2023 – In a first of its kind research analyzing micronutrients in blood, researchers have found that a...